Skip to main content
. Author manuscript; available in PMC: 2014 Oct 15.
Published in final edited form as: Toxicol Appl Pharmacol. 2013 Jul 13;272(2):384–390. doi: 10.1016/j.taap.2013.06.030

Figure 1.

Figure 1

In utero arsenic exposure and lifelong health effects. Human epidemiological studies (top) and experimental animal studies (bottom) demonstrate that in utero exposure to arsenic can impact health and disease development at different stages of life, from birth (leftmost gray panel) to childhood (center panel) and into adulthood (rightmost panel). In utero arsenic exposure may lead to different clinical presentation depending on the stage of life investigated, but examination of clinically relevant, intermediate endpoints in childhood may help to elucidate arsenic-related pathogenesis and later-life disease susceptibility.